Apotea AB (publ) (FRA:V30) Issuance of Debt: €2.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:V30 Apotea AB (publ) FRA:V30
16 GF Score
Price €6.98
! 1 Warning Sign
View Full Analysis

What is Apotea AB (publ) Issuance of Debt?

Apotea AB (publ) FRA:V30 -0.43% 16 Issuance of Debt is €2.0 Mil as of Jun. 2026. GuruFocus rates FRA:V30 with a GF Score™ of 16/100. The stock has 1 warning sign investors should review.

Apotea AB (publ)'s Issuance of Debt for the three months ended in Jun. 2026 was €0.0 Mil.

Apotea AB (publ)'s Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2026 was €2.0 Mil.

Apotea AB (publ) Issuance of Debt Related Terms

Apotea AB (publ) Issuance of Debt Historical Data

* Premium members only.

The historical data trend for Apotea AB (publ)'s Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apotea AB (publ) Issuance of Debt Chart

Apotea AB (publ) Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Issuance of Debt
0.00 10.17 5.98 6.92 1.99

Apotea AB (publ) Quarterly Data
Dec21 Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 1.99 0.00 0.00
FRA:V30
16GF Score
Apotea AB (publ) FRA:V30
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apotea AB (publ) Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of €2.0 Mil mean?
Apotea AB (publ) (FRA:V30) has a Issuance of Debt of €2.0 Mil as of Jun. 2026. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Apotea AB (publ) and its competitors.
Is Apotea AB (publ)'s Issuance of Debt too high?
Apotea AB (publ)'s current Issuance of Debt is €2.0 Mil. Overall, Apotea AB (publ) has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s Issuance of Debt compare to competitors?
Apotea AB (publ)'s Issuance of Debt of €2.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Healthcare Providers & Services company?
A good Issuance of Debt depends on the Healthcare Providers & Services industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Apotea AB (publ) and its competitors. Apotea AB (publ)'s current Issuance of Debt is €2.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (FRA:V30) has a current Issuance of Debt of €2.0 Mil. The current Issuance of Debt is €2.0 Mil. Apotea AB (publ)'s overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For Apotea AB (publ) (FRA:V30), the current Issuance of Debt is €2.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apotea AB (publ) Business Description

Other Exchanges APOTEA:SwedenV30:Germany
Address Sveavagen 168, Stockholm, SWE, 11346
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
16GF Score

Get the complete analysis for FRA:V30

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.98
Price